We bet on people. We are very selective, but when we find entrepreneurs with a unique combination of ambition, experience, leadership, and integrity, we are thrilled to support them with the long-term capital they need to succeed. In working with such exceptional entrepreneurs, we “first, do no harm”; where needed, we can bring significant value by helping make strategic decisions, recruit executives, secure industry contacts, and explore business development opportunities.
We also bet on products. We constantly ask ourselves “what will be the industry’s best-selling products 5-10 years from now?” and we find or build companies with such products. Our investment team remains up to date on global medical literature and clinical studies, as well as key opinion leader and industry expert insights.
At our core is a focus on quality science. LAV will not make an investment in low-quality products – we are not interested in “quick flip” investments built on hype. We will only make investments when attractive financial returns are aligned with the ethics of providing truly science-based, high-quality products to treat diseases and save lives.
Last but not the least, we are long-term thinkers. We are not driven by overnight success; instead, we are focused on building sustainable companies for the many decades ahead and catalyzing global medical innovations and humanity’s ever-increasing demand for better healthcare. This long-term thinking guides every investment decision, our organizational development, and the way we treat our partners.